nicofuranose

Chemical data

Formula

C30H24N4O10

Molecular weight

600.5 g/mol

IUPAC name

[(2R,3R,4S,5R)-5-hydroxy-3,4-bis(pyridine-3-carbonyloxy)-5-(pyridine-3-carbonyloxymethyl)oxolan-2-yl]methyl pyridine-3-carboxylate

SMILES

C1=CC(=CN=C1)C(=O)OC[C@@H]2[C@H]([C@@H]([C@](O2)(COC(=O)C3=CN=CC=C3)O)OC(=O)C4=CN=CC=C4)OC(=O)C5=CN=CC=C5

InChIKey

FUWFSXZKBMCSKF-ZASNTINBSA-N

XLogP

1.3

Polar surface area

186 Ų

H-bond donors

1

H-bond acceptors

14

Formal charge

0

via PubChem

Drug data · ChEMBL

Max clinical phase

Phase 2

Molecule type

Small molecule

Indications

cardiovascular disease

via ChEMBL · EBI

• Nicotinic acid plasma concentrations after ingestion of 1,3,4,6-tetranicotinoyl-fructo-furanose (tetranicotinoylfructose, nicofuranose).Current therapeutic research, clinical and experimental · 1974
• [Contribution to the therapy of blood circulation disorders with tetranicotinoyl-fructofuranose (Nicofuranose)].Therapeutische Umschau. Revue therapeutique · 1965
• Influence of age and K, Mg aspartate (Cardilan) on murine haemopoiesis.Mechanisms of ageing and development · 2000
• [ON THE USE OF AN ASSOCIATION OF CENTROPHENOXINE AND TETRANICOTINOYLFRUCTOSE IN PSYCHIATRY].Minerva medica · 1965
• [VASPERDIL IN THE TREATMENT OF PERIPHERAL VASCULAR DISEASES].Therapeutische Umschau. Revue therapeutique · 1964

via PubMed

Wikidata facts

Subclass of

chemical compound

Mass

600.149

via Wikidata · CC0